Share Price and Basic Stock Data
Last Updated: January 24, 2026, 3:58 pm
| PEG Ratio | 1.87 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gillanders Arbuthnot & Company Ltd operates primarily in the tea and coffee plantation industry. The company reported a market capitalization of ₹207 Cr and a share price of ₹95.4. The revenue from operations has shown fluctuations over the past quarters, with sales recorded at ₹144 Cr in September 2022, declining to ₹77 Cr by March 2023, before rebounding to ₹105 Cr in September 2023. However, the trailing twelve months (TTM) revenue stood at ₹452 Cr, indicating a modest recovery. The sales figures for recent quarters suggest a seasonal pattern, with an uptick expected in the latter half of the fiscal year. In the fiscal year ending March 2025, sales are expected to reach ₹443 Cr, reflecting a recovery from the previous year’s ₹363 Cr. This trend underscores the company’s potential for growth as market demand stabilizes following the volatility experienced during the pandemic years, where sales dipped to ₹431 Cr in FY 2021.
Profitability and Efficiency Metrics
Gillanders Arbuthnot’s profitability metrics reveal a challenging landscape, with a reported net profit of ₹24 Cr, translating to a return on equity (ROE) of 6.83% and a return on capital employed (ROCE) of 6.80%. Operating profit margin (OPM) stood at 15%, indicative of the company’s ability to manage its costs effectively in a competitive market. However, the company has faced significant profitability pressures recently, as evidenced by the operating profit turning negative in several quarters, such as a loss of ₹17 Cr in March 2023. The interest coverage ratio (ICR) was reported at 2.93x, suggesting that the company can comfortably meet its interest obligations despite profitability challenges. The cash conversion cycle (CCC) of 146 days indicates a relatively long duration for converting investments in inventory and accounts receivable back into cash, which may hinder liquidity.
Balance Sheet Strength and Financial Ratios
Gillanders Arbuthnot’s balance sheet reflects a cautious financial strategy, with total borrowings reported at ₹147 Cr against reserves of ₹234 Cr. This yields a total debt-to-equity ratio of 0.51, which is moderate compared to sector averages, suggesting a balanced approach to leveraging. The company’s current ratio stands at 0.96, indicating that it is slightly below the ideal threshold of 1, which could raise concerns about short-term liquidity. The book value per share was reported at ₹114.88, providing a cushion for shareholders amidst fluctuating profits. The interest coverage ratio of 2.93x highlights the company’s ability to meet its debt obligations, although the declining operating profit may affect future financial flexibility. Additionally, the reported enterprise value (EV) of ₹343.60 Cr relative to net operating revenue of ₹452 Cr suggests that the market is valuing the company reasonably well, despite the pressures on profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillanders Arbuthnot indicates a strong promoter backing, holding 69.05% of the shares, which provides stability and confidence to investors. The public holds 30.60%, while foreign institutional investors (FIIs) remain absent, indicating limited external interest. Domestic institutional investors (DIIs) hold a mere 0.31%, reflecting cautious sentiment among larger institutional players. The number of shareholders has shown growth, increasing from 9,553 in December 2022 to 10,245 by September 2025, indicating a growing interest among retail investors. This increase may correlate with the company’s recovery in sales and profitability metrics. The consistent promoter holding suggests a commitment to the company’s long-term vision, however, the lack of institutional support could hinder the stock’s performance in the broader market context.
Outlook, Risks, and Final Insight
Looking ahead, Gillanders Arbuthnot faces both opportunities and challenges. The potential for revenue growth exists if the company can stabilize its operating profits and manage its cash conversion cycle effectively. However, risks include continued volatility in commodity prices, which can impact profitability, and the potential for increased competition in the tea and coffee sector. Moreover, the company’s reliance on domestic markets may expose it to economic fluctuations. The absence of FIIs could limit capital inflow and stock liquidity, while high promoter concentration might deter broader investor participation. To improve its outlook, Gillanders Arbuthnot must focus on enhancing operational efficiencies and strategically leveraging its assets. If the company can navigate these risks effectively, it may present a compelling investment opportunity in a recovering market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 329 Cr. | 152 | 275/150 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 39.3 Cr. | 26.2 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 141 Cr. | 157 | 185/126 | 27.5 | 223 | 0.96 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 111 Cr. | 359 | 685/350 | 11.9 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,730.47 Cr | 378.93 | 65.13 | 265.00 | 0.45% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 144 | 103 | 77 | 88 | 105 | 101 | 69 | 85 | 127 | 128 | 104 | 88 | 132 |
| Expenses | 119 | 102 | 94 | 90 | 96 | 126 | 84 | 90 | 101 | 120 | 106 | 88 | 113 |
| Operating Profit | 24 | 1 | -17 | -3 | 9 | -24 | -16 | -5 | 25 | 8 | -2 | -0 | 20 |
| OPM % | 17% | 1% | -21% | -3% | 9% | -24% | -23% | -6% | 20% | 6% | -2% | -0% | 15% |
| Other Income | 4 | 6 | 8 | 5 | 2 | 8 | -1 | 2 | 4 | 13 | 4 | 0 | 3 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 21 | 0 | -16 | -5 | 4 | -23 | -22 | -10 | 23 | 15 | -4 | -6 | 16 |
| Tax % | 12% | -51% | -34% | 4% | 13% | -2% | 10% | 2% | 7% | 15% | -154% | -1% | 12% |
| Net Profit | 18 | 1 | -11 | -5 | 4 | -22 | -25 | -10 | 21 | 13 | 2 | -5 | 14 |
| EPS in Rs | 8.48 | 0.35 | -5.07 | -2.46 | 1.71 | -10.47 | -11.55 | -4.60 | 10.06 | 6.11 | 0.96 | -2.56 | 6.68 |
Last Updated: January 1, 2026, 4:16 pm
Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 132.00 Cr.. The value appears strong and on an upward trend. It has increased from 88.00 Cr. (Jun 2025) to 132.00 Cr., marking an increase of 44.00 Cr..
- For Expenses, as of Sep 2025, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 88.00 Cr. (Jun 2025) to 113.00 Cr., marking an increase of 25.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 20.00 Cr., marking an increase of 20.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 0.00% (Jun 2025) to 15.00%, marking an increase of 15.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 3.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from -6.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 22.00 Cr..
- For Tax %, as of Sep 2025, the value is 12.00%. The value appears to be increasing, which may not be favorable. It has increased from -1.00% (Jun 2025) to 12.00%, marking an increase of 13.00%.
- For Net Profit, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Jun 2025) to 14.00 Cr., marking an increase of 19.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.68. The value appears strong and on an upward trend. It has increased from -2.56 (Jun 2025) to 6.68, marking an increase of 9.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:20 am
| Metric | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 355 | 863 | 817 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 | 452 |
| Expenses | 333 | 821 | 812 | 653 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 | 427 |
| Operating Profit | 22 | 42 | 5 | 28 | 50 | 65 | 28 | 31 | 30 | 12 | -34 | 26 | 25 |
| OPM % | 6% | 5% | 1% | 4% | 7% | 9% | 4% | 7% | 7% | 3% | -9% | 6% | 6% |
| Other Income | 11 | 9 | 12 | 30 | 21 | 12 | 26 | 7 | 17 | 30 | 14 | 22 | 20 |
| Interest | 10 | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 | 12 |
| Depreciation | 9 | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 | 11 |
| Profit before tax | 14 | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 | 22 |
| Tax % | 21% | -27% | 4% | 4% | 112% | 95% | 22% | 2% | -42% | -22% | 6% | -7% | |
| Net Profit | 11 | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 | 24 |
| EPS in Rs | 6.69 | -4.16 | -25.93 | -8.83 | -4.02 | 0.15 | -7.13 | -7.32 | 7.66 | 6.94 | -22.78 | 12.52 | 11.19 |
| Dividend Payout % | 25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -511.11% | 65.45% | 52.63% | 100.00% | -6.67% | 200.00% | -6.25% | -426.67% | 155.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 576.57% | -12.82% | 47.37% | -106.67% | 206.67% | -206.25% | -420.42% | 581.77% |
Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -8% |
| 3 Years: | 3% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 0% |
| TTM: | 139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 34% |
| 3 Years: | 21% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:17 am
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 107 | 266 | 155 | 262 | 271 | 268 | 255 | 231 | 248 | 255 | 196 | 224 | 234 |
| Borrowings | 91 | 456 | 480 | 449 | 424 | 392 | 366 | 227 | 183 | 145 | 129 | 139 | 147 |
| Other Liabilities | 72 | 242 | 209 | 203 | 225 | 244 | 214 | 145 | 144 | 129 | 130 | 130 | 128 |
| Total Liabilities | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 | 530 |
| Fixed Assets | 112 | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 | 253 |
| CWIP | 10 | 11 | 4 | 9 | 17 | 14 | 15 | 14 | 12 | 11 | 9 | 13 | 16 |
| Investments | 13 | 28 | 28 | 29 | 34 | 29 | 17 | 8 | 3 | 0 | 0 | 0 | 0 |
| Other Assets | 145 | 525 | 522 | 457 | 460 | 454 | 404 | 287 | 271 | 241 | 205 | 245 | 260 |
| Total Assets | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 | 530 |
Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
- For Reserves, as of Sep 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 139.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 128.00 Cr.. The value appears to be improving (decreasing). It has decreased from 130.00 Cr. (Mar 2025) to 128.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 530.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 514.00 Cr. (Mar 2025) to 530.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 256.00 Cr. (Mar 2025) to 253.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 15.00 Cr..
- For Total Assets, as of Sep 2025, the value is 530.00 Cr.. The value appears strong and on an upward trend. It has increased from 514.00 Cr. (Mar 2025) to 530.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (234.00 Cr.) exceed the Borrowings (147.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.00 | -414.00 | -475.00 | -421.00 | -374.00 | -327.00 | -338.00 | -196.00 | -153.00 | -133.00 | -163.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 56 | 57 | 54 | 53 | 47 | 45 | 54 | 36 | 21 | 29 | 51 |
| Inventory Days | 130 | 135 | 156 | 207 | 253 | 219 | 206 | 240 | 389 | 287 | 314 | 225 |
| Days Payable | 97 | 92 | 112 | 148 | 180 | 166 | 164 | 163 | 220 | 129 | 164 | 130 |
| Cash Conversion Cycle | 59 | 99 | 101 | 113 | 126 | 100 | 87 | 130 | 204 | 179 | 180 | 146 |
| Working Capital Days | 72 | -21 | 1 | -6 | -24 | -25 | -47 | -11 | 2 | -1 | -11 | -7 |
| ROCE % | 10% | -0% | 1% | 6% | 8% | 4% | 4% | 7% | 4% | -8% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Diluted EPS (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| Cash EPS (Rs.) | 17.61 | -17.27 | 12.55 | 13.49 | 0.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.88 | 101.89 | 129.69 | 126.44 | 118.37 |
| Revenue From Operations / Share (Rs.) | 207.65 | 170.22 | 210.39 | 190.42 | 201.83 |
| PBDIT / Share (Rs.) | 16.98 | -9.36 | 14.78 | 22.12 | 18.70 |
| PBIT / Share (Rs.) | 11.89 | -14.87 | 9.18 | 16.29 | 11.19 |
| PBT / Share (Rs.) | 11.70 | -21.56 | 5.71 | 5.38 | -7.15 |
| Net Profit / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| NP After MI And SOA / Share (Rs.) | 12.52 | -22.78 | 6.95 | 7.66 | -7.32 |
| PBDIT Margin (%) | 8.17 | -5.50 | 7.02 | 11.61 | 9.26 |
| PBIT Margin (%) | 5.72 | -8.73 | 4.36 | 8.55 | 5.54 |
| PBT Margin (%) | 5.63 | -12.66 | 2.71 | 2.82 | -3.54 |
| Net Profit Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| NP After MI And SOA Margin (%) | 6.02 | -13.38 | 3.30 | 4.02 | -3.62 |
| Return on Networth / Equity (%) | 10.89 | -22.35 | 5.35 | 6.05 | -6.18 |
| Return on Capital Employeed (%) | 8.60 | -12.43 | 6.06 | 9.99 | 6.96 |
| Return On Assets (%) | 5.19 | -10.19 | 2.69 | 2.73 | -2.50 |
| Long Term Debt / Equity (X) | 0.05 | 0.08 | 0.09 | 0.21 | 0.30 |
| Total Debt / Equity (X) | 0.51 | 0.53 | 0.47 | 0.63 | 0.73 |
| Asset Turnover Ratio (%) | 0.89 | 0.70 | 0.78 | 0.64 | 0.56 |
| Current Ratio (X) | 0.96 | 0.85 | 1.01 | 1.03 | 0.99 |
| Quick Ratio (X) | 0.45 | 0.36 | 0.47 | 0.50 | 0.61 |
| Inventory Turnover Ratio (X) | 4.05 | 0.52 | 0.78 | 0.95 | 0.57 |
| Interest Coverage Ratio (X) | 2.93 | -1.40 | 1.75 | 2.03 | 1.08 |
| Interest Coverage Ratio (Post Tax) (X) | 2.20 | -2.41 | 1.23 | 1.70 | 0.63 |
| Enterprise Value (Cr.) | 343.60 | 282.86 | 273.58 | 318.10 | 271.78 |
| EV / Net Operating Revenue (X) | 0.77 | 0.77 | 0.60 | 0.78 | 0.63 |
| EV / EBITDA (X) | 9.48 | -14.15 | 8.67 | 6.74 | 6.81 |
| MarketCap / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| Price / BV (X) | 0.83 | 0.71 | 0.47 | 0.51 | 0.36 |
| Price / Net Operating Revenue (X) | 0.46 | 0.43 | 0.29 | 0.34 | 0.21 |
| EarningsYield | 0.13 | -0.31 | 0.11 | 0.11 | -0.16 |
After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.61. This value is within the healthy range. It has increased from -17.27 (Mar 24) to 17.61, marking an increase of 34.88.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.88. It has increased from 101.89 (Mar 24) to 114.88, marking an increase of 12.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 207.65. It has increased from 170.22 (Mar 24) to 207.65, marking an increase of 37.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.98. This value is within the healthy range. It has increased from -9.36 (Mar 24) to 16.98, marking an increase of 26.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from -14.87 (Mar 24) to 11.89, marking an increase of 26.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.70. This value is within the healthy range. It has increased from -21.56 (Mar 24) to 11.70, marking an increase of 33.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.52. This value is within the healthy range. It has increased from -22.78 (Mar 24) to 12.52, marking an increase of 35.30.
- For PBDIT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has increased from -5.50 (Mar 24) to 8.17, marking an increase of 13.67.
- For PBIT Margin (%), as of Mar 25, the value is 5.72. This value is below the healthy minimum of 10. It has increased from -8.73 (Mar 24) to 5.72, marking an increase of 14.45.
- For PBT Margin (%), as of Mar 25, the value is 5.63. This value is below the healthy minimum of 10. It has increased from -12.66 (Mar 24) to 5.63, marking an increase of 18.29.
- For Net Profit Margin (%), as of Mar 25, the value is 6.02. This value is within the healthy range. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 8. It has increased from -13.38 (Mar 24) to 6.02, marking an increase of 19.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.89. This value is below the healthy minimum of 15. It has increased from -22.35 (Mar 24) to 10.89, marking an increase of 33.24.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.60. This value is below the healthy minimum of 10. It has increased from -12.43 (Mar 24) to 8.60, marking an increase of 21.03.
- For Return On Assets (%), as of Mar 25, the value is 5.19. This value is within the healthy range. It has increased from -10.19 (Mar 24) to 5.19, marking an increase of 15.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.05, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.51. This value is within the healthy range. It has decreased from 0.53 (Mar 24) to 0.51, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.89. It has increased from 0.70 (Mar 24) to 0.89, marking an increase of 0.19.
- For Current Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1.5. It has increased from 0.85 (Mar 24) to 0.96, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has increased from 0.36 (Mar 24) to 0.45, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.05. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 4.05, marking an increase of 3.53.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 3. It has increased from -1.40 (Mar 24) to 2.93, marking an increase of 4.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 3. It has increased from -2.41 (Mar 24) to 2.20, marking an increase of 4.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 343.60. It has increased from 282.86 (Mar 24) to 343.60, marking an increase of 60.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.48. This value is within the healthy range. It has increased from -14.15 (Mar 24) to 9.48, marking an increase of 23.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.43 (Mar 24) to 0.46, marking an increase of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. It has increased from -0.31 (Mar 24) to 0.13, marking an increase of 0.44.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
- Net Profit Margin: 6.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.6% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.89% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.2
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.45
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.7 (Industry average Stock P/E: 65.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.51
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | C-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Kumar Kothari | Chairman |
| Mr. Mahesh Sodhani | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Non Executive Director |
| Mr. Arvind Baheti | Independent Director |
| Mr. Charudatta Raghvendra Prayag | Independent Director |
| Mr. Kothaneth Ashok | Independent Director |
FAQ
What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?
Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 26 January 2026) is ₹106.05 which is 12.34% higher the current market price of ₹94.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹201 Cr. market cap, FY2025-2026 high/low of ₹152/89.8, reserves of ₹234 Cr, and liabilities of ₹530 Cr.
What is the Market Cap of Gillanders Arbuthnot & Company Ltd?
The Market Cap of Gillanders Arbuthnot & Company Ltd is 201 Cr..
What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 26 January 2026?
The current stock price of Gillanders Arbuthnot & Company Ltd as on 26 January 2026 is ₹94.4.
What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is ₹152/89.8.
What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?
The Stock P/E of Gillanders Arbuthnot & Company Ltd is 14.7.
What is the Book Value of Gillanders Arbuthnot & Company Ltd?
The Book Value of Gillanders Arbuthnot & Company Ltd is 120.
What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?
The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.
What is the ROCE of Gillanders Arbuthnot & Company Ltd?
The ROCE of Gillanders Arbuthnot & Company Ltd is 6.80 %.
What is the ROE of Gillanders Arbuthnot & Company Ltd?
The ROE of Gillanders Arbuthnot & Company Ltd is 6.83 %.
What is the Face Value of Gillanders Arbuthnot & Company Ltd?
The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.